Amicus Therapeutics (FOLD)
NASDAQ:FOLD

Amicus (FOLD) Technical Analysis

808 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Amicus Therapeutics’s (FOLD) Moving Averages Convergence Divergence (MACD) indicator is -0.20, suggesting Amicus Therapeutics is a Buy.
Amicus Therapeutics’s (FOLD) 20-Day exponential moving average is 12.55, while Amicus Therapeutics’s (FOLD) share price is $12.16, making it a Sell.
Amicus Therapeutics’s (FOLD) 50-Day exponential moving average is 12.71, while Amicus Therapeutics’s (FOLD) share price is $12.16, making it a Sell.

Amicus (FOLD) Pivot Points

Oct 01, 2023, 12:04 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.67
10.54
11.20
12.07
12.73
13.59
14.25
Fibonacci
10.54
11.12
11.48
12.07
12.65
13.01
13.59
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Amicus (FOLD) Moving Averages

Oct 01, 2023, 12:04 PM
Period
Simple
Exponential
MA5
12.22Sell
12.23Sell
MA10
12.36Sell
12.37Sell
MA20
12.63Sell
12.55Sell
MA50
12.94Sell
12.71Sell
MA100
12.60Sell
12.58Sell
MA200
12.34Sell
12.27Sell
Amicus Therapeutics’s (FOLD) 10-Day exponential moving average is 12.37, while Amicus Therapeutics’s (FOLD) share price is $12.16, making it a Sell.
Amicus Therapeutics’s (FOLD) 100-Day exponential moving average is 12.58, while Amicus Therapeutics’s (FOLD) share price is $12.16, making it a Sell.
Amicus Therapeutics’s (FOLD) stock price is $12.16 and Amicus Therapeutics’s (FOLD) 50-day simple moving average is 12.94, creating a Sell signal.
Amicus Therapeutics’s (FOLD) stock price is $12.16 and Amicus Therapeutics’s (FOLD) 100-day simple moving average is 12.60, creating a Sell signal.
Amicus Therapeutics’s (FOLD) stock price is $12.16 and Amicus Therapeutics’s (FOLD) 200-day simple moving average is 12.34, creating a Sell signal.

Amicus (FOLD) Technical Indicators

Oct 01, 2023, 12:04 PM
Name
Value
Implied Action
RSI (14)
44.14
Neutral
STOCH (9,6)
49.53
Neutral
STOCHRSI (14)
39.59
Neutral
MACD (12,26)
-0.20
Buy
ADX (14)
19.39
Buy
Williams %R
-64.30
Buy
CCI (14)
-75.17
Neutral
ATR (14)
0.53
-
Ultimate Oscillator
50.02
Neutral
ROC
-8.50
Sell
Amicus Therapeutics’s (FOLD) Relative Strength Index (RSI) is 44.14, creating a Neutral signal.
Amicus Therapeutics’s (FOLD) Trend Strength Indicator (ADX) is 19.39, creating a Buy signal.
Amicus Therapeutics’s (FOLD) Commodity Channel Index (CCI) is -75.17, creating a Neutral signal.
Amicus Therapeutics’s (FOLD) Price Rate of Change (ROC) is -8.50, creating a Sell signal.

FAQ

Is FOLD a Buy, Hold, or Sell?
Based on FOLD’s technical indicators, FOLD is a Strong Sell.
    What is FOLD’s RSI (14)?
    FOLD’s RSI (14) is 44.14, which suggests FOLD is a Neutral.
      What is FOLD’s MACD?
      FOLD’s MACD is -0.20, which suggests FOLD is a Buy.
        What is FOLD’s 5-day moving average?
        FOLD’s 5-day moving average is 12.22, which suggests FOLD is a Sell.
          What is FOLD’s 20-day moving average?
          FOLD 20-day moving average is 12.63, which suggests FOLD is a Sell.
            What is FOLD’s 50-day moving average?
            FOLD’s 50-day moving average is 12.94, which suggests FOLD is a Sell.
              What is FOLD’s 200-day moving average?
              FOLD’s 200-day moving average is 12.34, which suggests FOLD is a Sell.
                What is FOLD’s Williams % R (14)?
                FOLD’s Williams % R (14) is -64.30, which suggests FOLD is a Buy.
                  What is FOLD’s CCI (14)?
                  FOLD’s CCI (14) is -75.17, which suggests FOLD is a Neutral.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis